Annual Report

Overview

The report describes Diaceutics' 2021 transition to the DXRX platform and recurring revenue model, with Group revenue of £13.9m and 60% of revenue generated through the platform. It presents the company's first ESG Statement, covering environmental practices, employee support, social responsibility and governance policies. The report also highlights investment in employee training, including almost 6,500 internal training hours, alongside continued platform and laboratory expansion.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2021
Period: 1 January 2021 – 31 December 2021
Publication date: 22 March 2022
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Materiality

Assessment
Basis

Assurance

Level
Standard
Scope
Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services